DK0585027T3 - Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning - Google Patents

Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning

Info

Publication number
DK0585027T3
DK0585027T3 DK93306445.3T DK93306445T DK0585027T3 DK 0585027 T3 DK0585027 T3 DK 0585027T3 DK 93306445 T DK93306445 T DK 93306445T DK 0585027 T3 DK0585027 T3 DK 0585027T3
Authority
DK
Denmark
Prior art keywords
fatty acids
abnormal tissue
tissue calcification
treat abnormal
prevention
Prior art date
Application number
DK93306445.3T
Other languages
Danish (da)
English (en)
Inventor
David Frederick Horrobin
Brenda Elizabeth Reynolds
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of DK0585027T3 publication Critical patent/DK0585027T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK93306445.3T 1992-08-21 1993-08-16 Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning DK0585027T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217781A GB9217781D0 (en) 1992-08-21 1992-08-21 Fatty acid treatment

Publications (1)

Publication Number Publication Date
DK0585027T3 true DK0585027T3 (da) 1998-05-11

Family

ID=10720717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93306445.3T DK0585027T3 (da) 1992-08-21 1993-08-16 Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning

Country Status (17)

Country Link
EP (1) EP0585027B1 (ko)
JP (1) JPH06172169A (ko)
KR (1) KR940003552A (ko)
CN (1) CN1090490A (ko)
AT (1) ATE164518T1 (ko)
AU (1) AU666748B2 (ko)
CA (1) CA2104566A1 (ko)
DE (1) DE69317716T2 (ko)
DK (1) DK0585027T3 (ko)
ES (1) ES2117104T3 (ko)
GB (1) GB9217781D0 (ko)
GR (1) GR3026708T3 (ko)
MY (1) MY131357A (ko)
NO (1) NO932984L (ko)
NZ (1) NZ248451A (ko)
RU (1) RU2122408C1 (ko)
ZA (1) ZA936133B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US5668174A (en) * 1993-12-29 1997-09-16 Kowa Tekuno Sachi Co., Ltd. Method of treating hyperparathyroidism
AU693312B2 (en) * 1995-01-18 1998-06-25 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
GB9617847D0 (en) 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
JP4607264B2 (ja) * 1998-12-01 2011-01-05 生化学工業株式会社 ヒアルロン酸を有効成分とする異所性石灰化抑制剤
EP1392278A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PRODUCTION AND USE OF A LIPID-RICH POLAR FRACTION CONTAINING STEARIDONIC ACID AND GAMMA-LINOLENIC ACID EXTRACTED FROM SEEDS AND MICROORGANISMS
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
JP4575105B2 (ja) * 2004-10-07 2010-11-04 ポリエン・プロジェクト有限会社 骨芽細胞活性抑制剤
CN103202483A (zh) * 2012-01-11 2013-07-17 浙江康恩贝健康产品有限公司 一种补钙营养组合物
WO2013192109A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
ES2877810T3 (es) * 2016-06-01 2021-11-17 Nestle Sa DGLA en la profilaxis de enfermedades alérgicas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3474633D1 (en) * 1984-02-01 1988-11-24 Tpo Pharmachim Means for the treatment and the prophylaxis of uratic and mixed uratic lithiasis
WO1987006463A1 (en) * 1986-05-02 1987-11-05 Brigham And Women's Hospital A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment

Also Published As

Publication number Publication date
NO932984D0 (no) 1993-08-20
NZ248451A (en) 1997-07-27
AU4474893A (en) 1994-02-24
NO932984L (no) 1994-02-22
GR3026708T3 (en) 1998-07-31
ES2117104T3 (es) 1998-08-01
EP0585027A1 (en) 1994-03-02
CA2104566A1 (en) 1994-02-22
ATE164518T1 (de) 1998-04-15
KR940003552A (ko) 1994-03-12
DE69317716D1 (de) 1998-05-07
RU2122408C1 (ru) 1998-11-27
GB9217781D0 (en) 1992-10-07
AU666748B2 (en) 1996-02-22
ZA936133B (en) 1994-03-17
CN1090490A (zh) 1994-08-10
MY131357A (en) 2007-08-30
DE69317716T2 (de) 1998-09-17
EP0585027B1 (en) 1998-04-01
JPH06172169A (ja) 1994-06-21

Similar Documents

Publication Publication Date Title
MY109928A (en) Fatty acid treatment
ATE43242T1 (de) Pharmazeutische oder diaetetische zusammensetzung mit hoher antithrombotischer und antiarteriosklerotischer wirkung.
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
IS2180B (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða steridónsýru
JPS6422819A (en) Amnesia treating or preventing composition
DK0585027T3 (da) Anvendelse af fedtsyrer til behandling af abnorm vævsforkalkning
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
RU93049092A (ru) Лечение жирными кислотами
ATE142491T1 (de) Mittel zur behandlung des atopischen ekzems und anderen entzündlichen hautkrankheiten